Logo image of SGML

SIGMA LITHIUM CORP (SGML) Stock Fundamental Analysis

USA - NASDAQ:SGML - CA8265991023 - Common Stock

6.84 USD
+0.63 (+10.14%)
Last: 10/20/2025, 8:16:04 PM
6.8852 USD
+0.05 (+0.66%)
After Hours: 10/20/2025, 8:16:04 PM
Fundamental Rating

2

SGML gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 155 industry peers in the Metals & Mining industry. SGML has a bad profitability rating. Also its financial health evaluation is rather negative. SGML has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SGML has reported negative net income.
SGML had a positive operating cash flow in the past year.
In the past 5 years SGML always reported negative net income.
In the past 5 years SGML always reported negative operating cash flow.
SGML Yearly Net Income VS EBIT VS OCF VS FCFSGML Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -16.91%, SGML is not doing good in the industry: 74.84% of the companies in the same industry are doing better.
With a Return On Equity value of -61.84%, SGML is not doing good in the industry: 85.16% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.91%
ROE -61.84%
ROIC N/A
ROA(3y)-21.3%
ROA(5y)-17.21%
ROE(3y)-46.67%
ROE(5y)-33.09%
ROIC(3y)N/A
ROIC(5y)N/A
SGML Yearly ROA, ROE, ROICSGML Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

1.3 Margins

SGML has a Gross Margin of 7.91%. This is in the lower half of the industry: SGML underperforms 60.00% of its industry peers.
SGML does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGML Yearly Profit, Operating, Gross MarginsSGML Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

SGML does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGML has more shares outstanding
SGML has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SGML is higher compared to a year ago.
SGML Yearly Shares OutstandingSGML Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SGML Yearly Total Debt VS Total AssetsSGML Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

SGML has an Altman-Z score of 0.68. This is a bad value and indicates that SGML is not financially healthy and even has some risk of bankruptcy.
SGML has a worse Altman-Z score (0.68) than 84.52% of its industry peers.
SGML has a debt to FCF ratio of 7.23. This is a slightly negative value and a sign of low solvency as SGML would need 7.23 years to pay back of all of its debts.
SGML's Debt to FCF ratio of 7.23 is fine compared to the rest of the industry. SGML outperforms 66.45% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that SGML has dependencies on debt financing.
With a Debt to Equity ratio value of 1.26, SGML is not doing good in the industry: 87.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 7.23
Altman-Z 0.68
ROIC/WACCN/A
WACC19.77%
SGML Yearly LT Debt VS Equity VS FCFSGML Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.60 indicates that SGML may have some problems paying its short term obligations.
With a Current ratio value of 0.60, SGML is not doing good in the industry: 91.61% of the companies in the same industry are doing better.
SGML has a Quick Ratio of 0.60. This is a bad value and indicates that SGML is not financially healthy enough and could expect problems in meeting its short term obligations.
SGML has a Quick ratio of 0.39. This is amonst the worse of the industry: SGML underperforms 91.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.39
SGML Yearly Current Assets VS Current LiabilitesSGML Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SGML have decreased strongly by -521.77% in the last year.
The Revenue for SGML has decreased by -51.93% in the past year. This is quite bad
EPS 1Y (TTM)-521.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-51.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-73.13%

3.2 Future

The Earnings Per Share is expected to grow by 42.82% on average over the next years. This is a very strong growth
Based on estimates for the next years, SGML will show a very strong growth in Revenue. The Revenue will grow by 31.94% on average per year.
EPS Next Y97.83%
EPS Next 2Y58.66%
EPS Next 3Y57.05%
EPS Next 5Y42.82%
Revenue Next Year-11%
Revenue Next 2Y20.75%
Revenue Next 3Y32.13%
Revenue Next 5Y31.94%

3.3 Evolution

SGML Yearly Revenue VS EstimatesSGML Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SGML Yearly EPS VS EstimatesSGML Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

SGML reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 21.33, SGML is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SGML indicates a somewhat cheap valuation: SGML is cheaper than 60.65% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.18. SGML is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 21.33
SGML Price Earnings VS Forward Price EarningsSGML Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SGML is valued cheaper than 80.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.08
EV/EBITDA N/A
SGML Per share dataSGML EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

SGML's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SGML's earnings are expected to grow with 57.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.66%
EPS Next 3Y57.05%

More info and screens

0

5. Dividend

5.1 Amount

SGML does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGMA LITHIUM CORP

NASDAQ:SGML (10/20/2025, 8:16:04 PM)

After market: 6.8852 +0.05 (+0.66%)

6.84

+0.63 (+10.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-15 2025-08-15/bmo
Earnings (Next)11-14 2025-11-14/amc
Inst Owners86.04%
Inst Owner Change0.5%
Ins Owners4.98%
Ins Owner ChangeN/A
Market Cap761.70M
Analysts82.86
Price Target9.16 (33.92%)
Short Float %7.99%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)250.01%
Min EPS beat(2)-68.32%
Max EPS beat(2)568.35%
EPS beat(4)1
Avg EPS beat(4)-41.96%
Min EPS beat(4)-424.24%
Max EPS beat(4)568.35%
EPS beat(8)1
Avg EPS beat(8)-82.76%
EPS beat(12)1
Avg EPS beat(12)-239.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-22.46%
Min Revenue beat(2)-54.81%
Max Revenue beat(2)9.89%
Revenue beat(4)1
Avg Revenue beat(4)-28.83%
Min Revenue beat(4)-61.22%
Max Revenue beat(4)9.89%
Revenue beat(8)1
Avg Revenue beat(8)-33.91%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-28.43%
PT rev (3m)-33.69%
EPS NQ rev (1m)-59.73%
EPS NQ rev (3m)162.64%
EPS NY rev (1m)-107.84%
EPS NY rev (3m)-109.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)60.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-31.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.33
P/S 5.38
P/FCF 32.08
P/OCF 25.33
P/B 8.29
P/tB 8.29
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)0.32
Fwd EY4.69%
FCF(TTM)0.21
FCFY3.12%
OCF(TTM)0.27
OCFY3.95%
SpS1.27
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.91%
ROE -61.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.91%
FCFM 16.77%
ROA(3y)-21.3%
ROA(5y)-17.21%
ROE(3y)-46.67%
ROE(5y)-33.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 7.23
Debt/EBITDA N/A
Cap/Depr 55.06%
Cap/Sales 4.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.39
Altman-Z 0.68
F-Score2
WACC19.77%
ROIC/WACCN/A
Cap/Depr(3y)42041.1%
Cap/Depr(5y)32140.2%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-521.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.77%
EPS Next Y97.83%
EPS Next 2Y58.66%
EPS Next 3Y57.05%
EPS Next 5Y42.82%
Revenue 1Y (TTM)-51.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-73.13%
Revenue Next Year-11%
Revenue Next 2Y20.75%
Revenue Next 3Y32.13%
Revenue Next 5Y31.94%
EBIT growth 1Y-145.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year207.3%
EBIT Next 3Y135.13%
EBIT Next 5Y89.98%
FCF growth 1Y111.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y148.1%
OCF growth 3YN/A
OCF growth 5YN/A